Normalisation is medical misogyny and delays diagnosis
Sharnelle Vella, ABC Radio Melbourne breakfast co-host[/caption]
Mike Stephens, Director, Medicines policy and Programs at the National Aboriginal Community Controlled Health Organisation (NACCHO)[/caption]
Chastina Heck MPS, Chair of the PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest (CSI).[/caption]
Philippa Chigeza, pharmacist at Logan Hospital.[/caption]
Stewart Mearns MPS[/caption]
Zara Gul[/caption]
Changes to AIR information
References
1. Australian Government Department of Health and Aged Care. Mandatory reporting changes to the Australian Immunisation Register (AIR) from 1 March 2024. 2024. At:...
Protecting kids from medicine harm
References
PSA. Medicine safety: child and adolescent care report. 2025. At: www.psa.org.au/3d-flip-book/medicine-safety-child-and-adolescent-care-report/
Cairns R, Karanges EA, Wong A, et al. Trends in self-poisoning and...
Long-acting treatment for opioid dependence approved
The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA).
Buvidal Weekly and Buvidal Monthly...
NSAIDs for older people, handle with care
References
Chan ASL, Saha S, Weeks GR, Taylor S, Whitty JA, Veerman JL, et al. Cost-effectiveness of a multidisciplinary team approach to the prevention...
Is the banana question distracting from real potassium risks?
When patients ask if they need to give up bananas, pharmacists can redirect the conversation to the real drivers of hyperkalaemia risk.
